Ivermectin during the COVID-19 pandemic (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ivermectin during the COVID-19 pandemic" in English language version.

refsWebsite

Global rank English rank

62web.archive.org

1^st place

53nih.gov

4^th place

32doi.org

2^nd place

10semanticscholar.org

11^th place

8^th place

7theguardian.com

12^th place

11^th place

3who.int

195^th place

302^nd place

3science.org

1,160^th place

737^th place

3the-scientist.com

7,827^th place

5,905^th place

3harvard.edu

18^th place

17^th place

3sciencebasedmedicine.org

5,063^rd place

3,360^th place

3vice.com

175^th place

137^th place

3europa.eu

68^th place

117^th place

2nytimes.com

7^th place

2worldcat.org

5^th place

2pebmed.com.br

low place

2sahpra.org.za

low place

2reuters.com

49^th place

47^th place

2apnews.com

129^th place

89^th place

2cdc.gov

218^th place

212^th place

1fda.gov

447^th place

338^th place

1idsociety.org

low place

1courthousenews.com

4,146^th place

2,310^th place

1bbc.com

20^th place

30^th place

1bbc.co.uk

8^th place

10^th place

1cbsnews.com

108^th place

80^th place

1retractionwatch.com

low place

1capital-cdmx.org

low place

1merck.com

6,464^th place

5,671^st place

1bmj.com

1,226^th place

1,421^st place

1infectologia.org.br

low place

1politico.eu

1,347^th place

909^th place

1elfinanciero.com.mx

2,940^th place

5,617^th place

1andina.pe

5,230^th place

low place

1extra.com.pe

low place

1usatoday.com

41^st place

34^th place

1indiatoday.in

94^th place

66^th place

1manilatimes.net

2,715^th place

1,480^th place

1elpais.com.co

3,119^th place

7,309^th place

1itajai.sc.gov.br

low place

1x.com

low place

1ghostarchive.org

32^nd place

21^st place

1newsweek.com

269^th place

201^st place

1bloomberg.com

99^th place

77^th place

1smh.com.au

132^nd place

96^th place

1biospace.com

low place

7,595^th place

1theintercept.com

2,523^rd place

1,574^th place

1inews.co.uk

1,084^th place

617^th place

1newshub.co.nz

3,440^th place

1,946^th place

1watson.ch

6,345^th place

low place

1isglobal.org

low place

1doximity.com

low place

1drew.edu

low place

1washingtonpost.com

34^th place

27^th place

1nature.com

234^th place

397^th place

1vox.com

484^th place

323^rd place

1medicalnewstoday.com

3,011^th place

2,709^th place

andina.pe

Andina (13 October 2020). "Covid-19: Minsa aprueba resolución que deja sin efecto el uso de tres medicamentos" (in Spanish). Agencia Peruana de Noticias. Archived from the original on 26 October 2021. Retrieved 23 December 2021.

apnews.com

Dupuy B (11 December 2020). "No evidence ivermectin is a miracle drug against COVID-19" (Fact check). AP News. Archived from the original on 28 December 2021. Retrieved 23 December 2021.
"Pfizer's new pill to prevent COVID-19 is not the same as ivermectin". AP NEWS. 1 October 2021. Archived from the original on 23 January 2022. Retrieved 23 January 2022.

bbc.co.uk

Schraer R (23 June 2021). "Covid: Ivermectin to be studied as possible treatment in UK". BBC News. Archived from the original on 15 December 2021. Retrieved 23 June 2021.

bbc.com

"Ivermectin: How false science created a Covid 'miracle' drug". BBC News. 6 October 2021. Archived from the original on 8 January 2022. Retrieved 26 December 2021.

biospace.com

"Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox". BioSpace. 15 October 2021. Archived from the original on 19 October 2021. Retrieved 18 October 2021.

bloomberg.com

Einhorn B, Kay C (13 October 2021). "Ivermectin Doesn't Help Covid, But Generic Drug Makers Are Cashing In". Bloomberg Businessweek. Archived from the original on 26 November 2021. Retrieved 30 December 2021.

bmj.com

"WHO updates its guidance on treatments for COVID-19". BMJ (Press release). 9 November 2023.

capital-cdmx.org

Cuenca A (4 February 2022). "Falso y engañoso estudio del GobCDMX sobre Ivermectina para tratar Covid". Capital CDMX (in Spanish). Archived from the original on 6 February 2022. Retrieved 6 February 2022.

cbsnews.com

Cohen L (17 January 2022). "Arkansas inmates who were given ivermectin to treat COVID in jail file federal lawsuit: "They used us as an experiment" - CBS News". www.cbsnews.com. Archived from the original on 30 May 2023. Retrieved 6 August 2023.

cdc.gov

"Presumptive Treatment and Screening for Strongyloidiasis, Infections Caused by Other Soil-Transmitted Helminths, and Schistosomiasis among Newly Arrived Refugees". Division of Global Migration and Quarantine. Centers for Disease Control and Prevention. Immigrant, Refugee, and Migrant Health. Atlanta. 16 March 2021. Retrieved 12 May 2023.

emergency.cdc.gov

"Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19" (Health alert). Centers for Disease Control and Prevention. 26 August 2021. Archived from the original on 19 October 2021. Retrieved 1 January 2022.

courthousenews.com

Langford C (1 September 2023). "Fifth Circuit sides with ivermectin-prescribing doctors in their quarrel with the FDA". Courthouse News Service.

doi.org

Tafoya QJ (2021). "Appendix – COVID-19-Directed Medications". In Ramadan AR, Gamaleldin O (eds.). Neurological Care and the COVID-19 Pandemic (1st ed.). Elsevier. pp. 173–174. doi:10.1016/B978-0-323-82691-4.00016-9. ISBN 978-0-323-82691-4. S2CID 239763031. The WHO, the European Medicines Agency, and the IDSA all recommend against the use of ivermectin for treatment of COVID-19, with the NIH stating that there is insufficient data to recommend for or against its use outside the context of a clinical trial. (subscription required)
Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM (June 2020). "The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro". Antiviral Research. 178: 104787. doi:10.1016/j.antiviral.2020.104787. PMC 7129059. PMID 32251768.
Popp M, Reis S, Schießer S, Hausinger RI, Stegemann M, et al. (June 2022). "Ivermectin for preventing and treating COVID-19". Cochrane Database Syst Rev (Systematic review). 2022 (6): CD015017. doi:10.1002/14651858.CD015017.pub3. PMC 9215332. PMID 35726131.
Reis G, Silva EA, Silva DC, Thabane L, Milagres AC, et al. (May 2022). "Effect of Early Treatment with Ivermectin among Patients with Covid-19". N Engl J Med (Randomized controlled trial). 386 (18): 1721–1731. doi:10.1056/NEJMoa2115869. PMC 9006771. PMID 35353979.
Lawrence JM, Meyerowitz-Katz G, Heathers JA, Brown NJ, Sheldrick KA (November 2021). "The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable". Nature Medicine. 27 (11): 1853–1854. doi:10.1038/s41591-021-01535-y. PMID 34552263. S2CID 237607620.
Heidary F, Gharebaghi R (September 2020). "Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen". The Journal of Antibiotics. 73 (9): 593–602. doi:10.1038/s41429-020-0336-z. PMC 7290143. PMID 32533071.
Şimşek Yavuz S, Ünal S (April 2020). "Antiviral treatment of COVID-19". Turkish Journal of Medical Sciences. 50 (SI-1): 611–619. doi:10.3906/sag-2004-145. PMC 7195979. PMID 32293834.
Bray M, Rayner C, Noël F, Jans D, Wagstaff K (June 2020). "Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses". Antiviral Research. 178: 104805. doi:10.1016/j.antiviral.2020.104805. PMC 7172803. PMID 32330482.
López-Medina E, López P, Hurtado IC, Dávalos DM, Ramirez O, et al. (April 2021). "Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial". JAMA. 325 (14): 1426–1435. doi:10.1001/jama.2021.3071. PMC 7934083. PMID 33662102.
Yang SN, Atkinson SC, Wang C, Lee A, Bogoyevitch MA, et al. (May 2020). "The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer". Antiviral Research. 177: 104760. doi:10.1016/j.antiviral.2020.104760. PMID 32135219. S2CID 212565030.
Garegnani LI, Madrid E, Meza N (April 2021). "Misleading clinical evidence and systematic reviews on ivermectin for COVID-19". BMJ Evidence-Based Medicine. 27 (3): 156–158. doi:10.1136/bmjebm-2021-111678. PMID 33888547. S2CID 233354977.
Wagstaff K, Sivakumaran H, Heaton S, Harrich D, Jans D (1 May 2012). "Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus". Biochemical Journal. 443 (Pt 3): 851–856. doi:10.1042/BJ20120150. ISSN 0264-6021. PMC 3327999. PMID 22417684.
Kosyna FK, Depping R (November 2018). "Controlling the Gatekeeper: Therapeutic Targeting of Nuclear Transport". Cells. 7 (11): 221. doi:10.3390/cells7110221. PMC 6262578. PMID 30469340.
Harris GH, Adalja AA (November 2023). "Innovative approaches to COVID-19 medical countermeasure development". J Antimicrob Chemother (Review). 78 (Supplement_2): ii18–ii24. doi:10.1093/jac/dkad312. PMC 10667002. PMID 37995353.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Gentile N, et al. (October 2022). "Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial". JAMA. 328 (16): 1595–1603. doi:10.1001/jama.2022.18590. PMC 9587497. PMID 36269852.
Bartoszko JJ, Siemieniuk RA, Kum E, Qasim A, Zeraatkar D, et al. (April 2021). "Prophylaxis against covid-19: living systematic review and network meta-analysis". BMJ (Systematic review). 373: n949. doi:10.1136/bmj.n949. PMC 8073806. PMID 33903131.
Roman YM, Burela PA, Pasupuleti V, Piscoya A, Vidal JE, et al. (June 2021). "Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials". Clinical Infectious Diseases. 74 (6): 1022–1029. doi:10.1093/cid/ciab591. PMC 8394824. PMID 34181716.
Reardon S (August 2021). "Flawed ivermectin preprint highlights challenges of COVID drug studies". Nature. 596 (7871): 173–174. Bibcode:2021Natur.596..173R. doi:10.1038/d41586-021-02081-w. PMID 34341573. S2CID 236883132.
Manu P (7 February 2022). "Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Am J Ther. 2021;28(4): e434-e460". American Journal of Therapeutics. 29 (2): e232. doi:10.1097/CND.0000000000000400. PMC 9946064. PMID 35142702.
Manu P (7 February 2022). "Expression of Concern for Kory P, Meduri GU, Varon J, Iglesias J, Marik PE. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021;28(3) e299–e318". American Journal of Therapeutics. 29 (2): e231. doi:10.1097/MJT.0000000000001481. PMC 10501341. PMID 35142703. S2CID 246701186.
Wadvalla BA (April 2021). "Covid-19: Ivermectin's politicisation is a warning sign for doctors turning to orphan treatments". BMJ. 373: n747. doi:10.1136/bmj.n747. PMID 33795225. S2CID 232484313.
Bitterman A, Martins CP, Cices A, Nadendla MP (2022). "Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis: A Meta-analysis". JAMA Network Open. 5 (3): e223079. doi:10.1001/jamanetworkopen.2022.3079. PMC 8938718. PMID 35311963.
Eslahi AV, Badri M, Nahavandi KH, Houshmand E, Dalvand S, et al. (2021). "Prevalence of strongyloidiasis in the general population of the world: a systematic review and meta-analysis". Pathogens and Global Health. 115 (1): 7–20. doi:10.1080/20477724.2020.1851922. PMC 7850468. PMID 33433291.
Czeresnia JM, Weiss LM (2022). "Strongyloides stercoralis". Lung. 200 (2): 141–148. doi:10.1007/s00408-022-00528-z. PMC 8994069. PMID 35396957.
European Centre for Disease Prevention and Control. (2018). "Strongyloidiasis and schistosomiasis". Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA (PDF) (Report). Stockholm: European Centre for Disease Prevention and Control. p. 40. doi:10.2900/154411. ISBN 978-92-9498-280-3. Retrieved 12 May 2023.
Covid - O, Table SA, Biologics Clinical Practice Guidelines Working Group (2021). "Ivermectin treatment for Strongyloides infection in patients with COVID-19". Canada Communicable Disease Report. 47 (7/8): 316–321. doi:10.14745/ccdr.v47i78a04. PMC 8454299. PMID 34667442.
Mega ER (October 2020). "Latin America's embrace of an unproven COVID treatment is hindering drug trials". Nature. 586 (7830): 481–482. Bibcode:2020Natur.586..481M. doi:10.1038/d41586-020-02958-2. PMID 33077974. S2CID 224812404.
Molento MB (December 2020). "COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution". One Health. 10. Elsevier BV: 100148. doi:10.1016/j.onehlt.2020.100148. PMC 7313521. PMID 32632377.
Barnett ML, Gaye M, Jena AB, Mehrotra A (February 2022). "Association of County-Level Prescriptions for Hydroxychloroquine and Ivermectin With County-Level Political Voting Patterns in the 2020 US Presidential Election". JAMA Intern Med. 182 (4): 452–454. doi:10.1001/jamainternmed.2022.0200. PMC 8980920. PMID 35179552. S2CID 246943373.
Molento MB (December 2021). "Ivermectin against COVID-19: The unprecedented consequences in Latin America". One Health. 13: 100250. doi:10.1016/j.onehlt.2021.100250. PMC 8050401. PMID 33880395.
Deeks JJ, Higgins JP, Altman DG, et al. (Cochrane Statistical Methods Group) (26 September 2008). "Analysing Data and Undertaking Meta-Analyses". Cochrane Handbook for Systematic Reviews of Interventions. pp. 243–296. doi:10.1002/9780470712184.ch9. ISBN 9780470712184.
Nogrady B (13 October 2021). "'I hope you die': how the COVID pandemic unleashed attacks on scientists". Nature (News feature). 598 (7880): 250–253. Bibcode:2021Natur.598..250N. doi:10.1038/d41586-021-02741-x. PMID 34645996. S2CID 238858471. Archived from the original on 18 January 2022. Retrieved 3 January 2022.

doximity.com

opmed.doximity.com

Davis JJ. "Will Ivermectin Cure COVID-19?". opmed.doximity.com. Archived from the original on 25 May 2021. Retrieved 23 June 2021.

drew.edu

"Drew University Nobel Prize Winner Refutes Ivermectin Meme". Drew University. September 2021. Archived from the original on 15 January 2022. Retrieved 15 January 2022.

elfinanciero.com.mx

Ferrer A (22 January 2021). "Médicos en CDMX suministran ivermectina y azitromicina para tratar pacientes con COVID-19". El Financiero (in Spanish). Archived from the original on 23 October 2021. Retrieved 18 July 2021.

elpais.com.co

Casa Editorial El País Cali. "Empezarán a usar Ivermectina en tratamiento de pacientes covid en Cali, dice Ospina". elpais.com.co (in Spanish). El País. Archived from the original on 22 December 2021. Retrieved 12 July 2021.

europa.eu

ema.europa.eu

"EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials". News. European Medicines Agency. Amsterdam. 22 March 2021. Retrieved 12 May 2023.
"EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials" (Press release). European Medicines Agency. 22 March 2021. Archived from the original on 17 January 2022. Retrieved 23 December 2021.

ecdc.europa.eu

European Centre for Disease Prevention and Control. (2018). "Strongyloidiasis and schistosomiasis". Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA (PDF) (Report). Stockholm: European Centre for Disease Prevention and Control. p. 40. doi:10.2900/154411. ISBN 978-92-9498-280-3. Retrieved 12 May 2023.

extra.com.pe

Calderon D (22 January 2021). "Ivermectina vuelve a ser incluida en tratamiento covid-19". Diario Extra (in Spanish). Extra. Archived from the original on 26 October 2021. Retrieved 23 December 2021.

fda.gov

"Why You Should Not Use Ivermectin to Treat or Prevent COVID-19". United States Food and Drug Administration. Consumer Updates. Silver Spring, Maryland: Food and Drug Administration. 10 December 2021. Retrieved 12 May 2023.

ghostarchive.org

"Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19" (Health alert). Centers for Disease Control and Prevention. 26 August 2021. Archived from the original on 19 October 2021. Retrieved 1 January 2022.

harvard.edu

ui.adsabs.harvard.edu

Reardon S (August 2021). "Flawed ivermectin preprint highlights challenges of COVID drug studies". Nature. 596 (7871): 173–174. Bibcode:2021Natur.596..173R. doi:10.1038/d41586-021-02081-w. PMID 34341573. S2CID 236883132.
Mega ER (October 2020). "Latin America's embrace of an unproven COVID treatment is hindering drug trials". Nature. 586 (7830): 481–482. Bibcode:2020Natur.586..481M. doi:10.1038/d41586-020-02958-2. PMID 33077974. S2CID 224812404.
Nogrady B (13 October 2021). "'I hope you die': how the COVID pandemic unleashed attacks on scientists". Nature (News feature). 598 (7880): 250–253. Bibcode:2021Natur.598..250N. doi:10.1038/d41586-021-02741-x. PMID 34645996. S2CID 238858471. Archived from the original on 18 January 2022. Retrieved 3 January 2022.

idsociety.org

"IDSA Guidelines on the Treatment and Management of Patients with COVID-19: Recommendations 23-24: Ivermectin". Infectious Diseases Society of America. IDSA Practice Guidelines. Arlington, Virginia. 11 April 2023. Retrieved 12 May 2023.

indiatoday.in

Mordani S (7 June 2021). "DGHS drops Ivermectin, Doxycycline from Covid-19 treatment; ICMR rules unchanged". India Today. Archived from the original on 24 December 2021. Retrieved 18 July 2021.

inews.co.uk

Sharma R (24 February 2021). "What is Ivermectin? Why social media creates Covid 'miracle drugs' – and why you shouldn't trust the crowd". inews.co.uk. Archived from the original on 23 December 2021. Retrieved 23 December 2021.

infectologia.org.br

"Atualizações e Recomendações sobre a Covid-19" [Updates and recommendations on Covid-19] (PDF) (in Portuguese). Sociedade Brasileira de Infectologia. 9 December 2020. Archived (PDF) from the original on 20 October 2021. Retrieved 23 December 2021.

isglobal.org

Chaccour C. "Ivermectin and COVID-19: How a Flawed Database Shaped the Pandemic Response of Several Latin-American Countries - Blog". ISGlobal. Archived from the original on 6 November 2021. Retrieved 23 June 2021.

itajai.sc.gov.br

Prefeitura de Itajaí (6 July 311). "Itajaí vai implantar tratamento profilático à COVID-19 | Município de Itajaí". Prefeitura de Itajaí. Archived from the original on 22 December 2021. Retrieved 22 December 2021.

manilatimes.net

"FDA approves drug company's request to manufacture ivermectin". The Manila Times. 7 May 2021. Archived from the original on 23 December 2021. Retrieved 18 July 2021.

medicalnewstoday.com

Meyerowitz-Katz G (11 December 2021). "'Science is flawed': COVID-19, ivermectin, and beyond". Medical News Today. Archived from the original on 12 January 2022. Retrieved 28 December 2021.

merck.com

"Merck Statement on Ivermectin use During the COVID-19 Pandemic". Merck. 4 February 2021. Archived from the original on 16 January 2022. Retrieved 23 December 2021.

nature.com

Nogrady B (13 October 2021). "'I hope you die': how the COVID pandemic unleashed attacks on scientists". Nature (News feature). 598 (7880): 250–253. Bibcode:2021Natur.598..250N. doi:10.1038/d41586-021-02741-x. PMID 34645996. S2CID 238858471. Archived from the original on 18 January 2022. Retrieved 3 January 2022.

newshub.co.nz

Satherley D (26 November 2021). "Did mutations or ivermectin help stamp out Delta in Japan?". Newshub (Fact check). Archived from the original on 14 January 2022. Retrieved 23 December 2021.

newsweek.com

Bond P (22 March 2024). "FDA settles lawsuit over Ivermectin social media posts". Newsweek. Retrieved 25 March 2024.

nih.gov

pubmed.ncbi.nlm.nih.gov

Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM (June 2020). "The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro". Antiviral Research. 178: 104787. doi:10.1016/j.antiviral.2020.104787. PMC 7129059. PMID 32251768.
Popp M, Reis S, Schießer S, Hausinger RI, Stegemann M, et al. (June 2022). "Ivermectin for preventing and treating COVID-19". Cochrane Database Syst Rev (Systematic review). 2022 (6): CD015017. doi:10.1002/14651858.CD015017.pub3. PMC 9215332. PMID 35726131.
Reis G, Silva EA, Silva DC, Thabane L, Milagres AC, et al. (May 2022). "Effect of Early Treatment with Ivermectin among Patients with Covid-19". N Engl J Med (Randomized controlled trial). 386 (18): 1721–1731. doi:10.1056/NEJMoa2115869. PMC 9006771. PMID 35353979.
Lawrence JM, Meyerowitz-Katz G, Heathers JA, Brown NJ, Sheldrick KA (November 2021). "The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable". Nature Medicine. 27 (11): 1853–1854. doi:10.1038/s41591-021-01535-y. PMID 34552263. S2CID 237607620.
Heidary F, Gharebaghi R (September 2020). "Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen". The Journal of Antibiotics. 73 (9): 593–602. doi:10.1038/s41429-020-0336-z. PMC 7290143. PMID 32533071.
Şimşek Yavuz S, Ünal S (April 2020). "Antiviral treatment of COVID-19". Turkish Journal of Medical Sciences. 50 (SI-1): 611–619. doi:10.3906/sag-2004-145. PMC 7195979. PMID 32293834.
Bray M, Rayner C, Noël F, Jans D, Wagstaff K (June 2020). "Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses". Antiviral Research. 178: 104805. doi:10.1016/j.antiviral.2020.104805. PMC 7172803. PMID 32330482.
López-Medina E, López P, Hurtado IC, Dávalos DM, Ramirez O, et al. (April 2021). "Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial". JAMA. 325 (14): 1426–1435. doi:10.1001/jama.2021.3071. PMC 7934083. PMID 33662102.
Yang SN, Atkinson SC, Wang C, Lee A, Bogoyevitch MA, et al. (May 2020). "The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer". Antiviral Research. 177: 104760. doi:10.1016/j.antiviral.2020.104760. PMID 32135219. S2CID 212565030.
Garegnani LI, Madrid E, Meza N (April 2021). "Misleading clinical evidence and systematic reviews on ivermectin for COVID-19". BMJ Evidence-Based Medicine. 27 (3): 156–158. doi:10.1136/bmjebm-2021-111678. PMID 33888547. S2CID 233354977.
Wagstaff K, Sivakumaran H, Heaton S, Harrich D, Jans D (1 May 2012). "Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus". Biochemical Journal. 443 (Pt 3): 851–856. doi:10.1042/BJ20120150. ISSN 0264-6021. PMC 3327999. PMID 22417684.
Kosyna FK, Depping R (November 2018). "Controlling the Gatekeeper: Therapeutic Targeting of Nuclear Transport". Cells. 7 (11): 221. doi:10.3390/cells7110221. PMC 6262578. PMID 30469340.
Harris GH, Adalja AA (November 2023). "Innovative approaches to COVID-19 medical countermeasure development". J Antimicrob Chemother (Review). 78 (Supplement_2): ii18–ii24. doi:10.1093/jac/dkad312. PMC 10667002. PMID 37995353.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Gentile N, et al. (October 2022). "Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial". JAMA. 328 (16): 1595–1603. doi:10.1001/jama.2022.18590. PMC 9587497. PMID 36269852.
Bartoszko JJ, Siemieniuk RA, Kum E, Qasim A, Zeraatkar D, et al. (April 2021). "Prophylaxis against covid-19: living systematic review and network meta-analysis". BMJ (Systematic review). 373: n949. doi:10.1136/bmj.n949. PMC 8073806. PMID 33903131.
Roman YM, Burela PA, Pasupuleti V, Piscoya A, Vidal JE, et al. (June 2021). "Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials". Clinical Infectious Diseases. 74 (6): 1022–1029. doi:10.1093/cid/ciab591. PMC 8394824. PMID 34181716.
Reardon S (August 2021). "Flawed ivermectin preprint highlights challenges of COVID drug studies". Nature. 596 (7871): 173–174. Bibcode:2021Natur.596..173R. doi:10.1038/d41586-021-02081-w. PMID 34341573. S2CID 236883132.
Manu P (7 February 2022). "Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Am J Ther. 2021;28(4): e434-e460". American Journal of Therapeutics. 29 (2): e232. doi:10.1097/CND.0000000000000400. PMC 9946064. PMID 35142702.
Manu P (7 February 2022). "Expression of Concern for Kory P, Meduri GU, Varon J, Iglesias J, Marik PE. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021;28(3) e299–e318". American Journal of Therapeutics. 29 (2): e231. doi:10.1097/MJT.0000000000001481. PMC 10501341. PMID 35142703. S2CID 246701186.
Wadvalla BA (April 2021). "Covid-19: Ivermectin's politicisation is a warning sign for doctors turning to orphan treatments". BMJ. 373: n747. doi:10.1136/bmj.n747. PMID 33795225. S2CID 232484313.
Bitterman A, Martins CP, Cices A, Nadendla MP (2022). "Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis: A Meta-analysis". JAMA Network Open. 5 (3): e223079. doi:10.1001/jamanetworkopen.2022.3079. PMC 8938718. PMID 35311963.
Eslahi AV, Badri M, Nahavandi KH, Houshmand E, Dalvand S, et al. (2021). "Prevalence of strongyloidiasis in the general population of the world: a systematic review and meta-analysis". Pathogens and Global Health. 115 (1): 7–20. doi:10.1080/20477724.2020.1851922. PMC 7850468. PMID 33433291.
Czeresnia JM, Weiss LM (2022). "Strongyloides stercoralis". Lung. 200 (2): 141–148. doi:10.1007/s00408-022-00528-z. PMC 8994069. PMID 35396957.
Covid - O, Table SA, Biologics Clinical Practice Guidelines Working Group (2021). "Ivermectin treatment for Strongyloides infection in patients with COVID-19". Canada Communicable Disease Report. 47 (7/8): 316–321. doi:10.14745/ccdr.v47i78a04. PMC 8454299. PMID 34667442.
Mega ER (October 2020). "Latin America's embrace of an unproven COVID treatment is hindering drug trials". Nature. 586 (7830): 481–482. Bibcode:2020Natur.586..481M. doi:10.1038/d41586-020-02958-2. PMID 33077974. S2CID 224812404.
Molento MB (December 2020). "COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution". One Health. 10. Elsevier BV: 100148. doi:10.1016/j.onehlt.2020.100148. PMC 7313521. PMID 32632377.
Barnett ML, Gaye M, Jena AB, Mehrotra A (February 2022). "Association of County-Level Prescriptions for Hydroxychloroquine and Ivermectin With County-Level Political Voting Patterns in the 2020 US Presidential Election". JAMA Intern Med. 182 (4): 452–454. doi:10.1001/jamainternmed.2022.0200. PMC 8980920. PMID 35179552. S2CID 246943373.
Molento MB (December 2021). "Ivermectin against COVID-19: The unprecedented consequences in Latin America". One Health. 13: 100250. doi:10.1016/j.onehlt.2021.100250. PMC 8050401. PMID 33880395.
Nogrady B (13 October 2021). "'I hope you die': how the COVID pandemic unleashed attacks on scientists". Nature (News feature). 598 (7880): 250–253. Bibcode:2021Natur.598..250N. doi:10.1038/d41586-021-02741-x. PMID 34645996. S2CID 238858471. Archived from the original on 18 January 2022. Retrieved 3 January 2022.

ncbi.nlm.nih.gov

Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM (June 2020). "The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro". Antiviral Research. 178: 104787. doi:10.1016/j.antiviral.2020.104787. PMC 7129059. PMID 32251768.
Popp M, Reis S, Schießer S, Hausinger RI, Stegemann M, et al. (June 2022). "Ivermectin for preventing and treating COVID-19". Cochrane Database Syst Rev (Systematic review). 2022 (6): CD015017. doi:10.1002/14651858.CD015017.pub3. PMC 9215332. PMID 35726131.
Reis G, Silva EA, Silva DC, Thabane L, Milagres AC, et al. (May 2022). "Effect of Early Treatment with Ivermectin among Patients with Covid-19". N Engl J Med (Randomized controlled trial). 386 (18): 1721–1731. doi:10.1056/NEJMoa2115869. PMC 9006771. PMID 35353979.
Heidary F, Gharebaghi R (September 2020). "Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen". The Journal of Antibiotics. 73 (9): 593–602. doi:10.1038/s41429-020-0336-z. PMC 7290143. PMID 32533071.
Şimşek Yavuz S, Ünal S (April 2020). "Antiviral treatment of COVID-19". Turkish Journal of Medical Sciences. 50 (SI-1): 611–619. doi:10.3906/sag-2004-145. PMC 7195979. PMID 32293834.
Bray M, Rayner C, Noël F, Jans D, Wagstaff K (June 2020). "Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses". Antiviral Research. 178: 104805. doi:10.1016/j.antiviral.2020.104805. PMC 7172803. PMID 32330482.
López-Medina E, López P, Hurtado IC, Dávalos DM, Ramirez O, et al. (April 2021). "Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial". JAMA. 325 (14): 1426–1435. doi:10.1001/jama.2021.3071. PMC 7934083. PMID 33662102.
Wagstaff K, Sivakumaran H, Heaton S, Harrich D, Jans D (1 May 2012). "Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus". Biochemical Journal. 443 (Pt 3): 851–856. doi:10.1042/BJ20120150. ISSN 0264-6021. PMC 3327999. PMID 22417684.
Kosyna FK, Depping R (November 2018). "Controlling the Gatekeeper: Therapeutic Targeting of Nuclear Transport". Cells. 7 (11): 221. doi:10.3390/cells7110221. PMC 6262578. PMID 30469340.
Harris GH, Adalja AA (November 2023). "Innovative approaches to COVID-19 medical countermeasure development". J Antimicrob Chemother (Review). 78 (Supplement_2): ii18–ii24. doi:10.1093/jac/dkad312. PMC 10667002. PMID 37995353.
Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Gentile N, et al. (October 2022). "Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial". JAMA. 328 (16): 1595–1603. doi:10.1001/jama.2022.18590. PMC 9587497. PMID 36269852.
Bartoszko JJ, Siemieniuk RA, Kum E, Qasim A, Zeraatkar D, et al. (April 2021). "Prophylaxis against covid-19: living systematic review and network meta-analysis". BMJ (Systematic review). 373: n949. doi:10.1136/bmj.n949. PMC 8073806. PMID 33903131.
Roman YM, Burela PA, Pasupuleti V, Piscoya A, Vidal JE, et al. (June 2021). "Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials". Clinical Infectious Diseases. 74 (6): 1022–1029. doi:10.1093/cid/ciab591. PMC 8394824. PMID 34181716.
Manu P (7 February 2022). "Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Am J Ther. 2021;28(4): e434-e460". American Journal of Therapeutics. 29 (2): e232. doi:10.1097/CND.0000000000000400. PMC 9946064. PMID 35142702.
Manu P (7 February 2022). "Expression of Concern for Kory P, Meduri GU, Varon J, Iglesias J, Marik PE. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021;28(3) e299–e318". American Journal of Therapeutics. 29 (2): e231. doi:10.1097/MJT.0000000000001481. PMC 10501341. PMID 35142703. S2CID 246701186.
Bitterman A, Martins CP, Cices A, Nadendla MP (2022). "Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis: A Meta-analysis". JAMA Network Open. 5 (3): e223079. doi:10.1001/jamanetworkopen.2022.3079. PMC 8938718. PMID 35311963.
Eslahi AV, Badri M, Nahavandi KH, Houshmand E, Dalvand S, et al. (2021). "Prevalence of strongyloidiasis in the general population of the world: a systematic review and meta-analysis". Pathogens and Global Health. 115 (1): 7–20. doi:10.1080/20477724.2020.1851922. PMC 7850468. PMID 33433291.
Czeresnia JM, Weiss LM (2022). "Strongyloides stercoralis". Lung. 200 (2): 141–148. doi:10.1007/s00408-022-00528-z. PMC 8994069. PMID 35396957.
Covid - O, Table SA, Biologics Clinical Practice Guidelines Working Group (2021). "Ivermectin treatment for Strongyloides infection in patients with COVID-19". Canada Communicable Disease Report. 47 (7/8): 316–321. doi:10.14745/ccdr.v47i78a04. PMC 8454299. PMID 34667442.
Molento MB (December 2020). "COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution". One Health. 10. Elsevier BV: 100148. doi:10.1016/j.onehlt.2020.100148. PMC 7313521. PMID 32632377.
Barnett ML, Gaye M, Jena AB, Mehrotra A (February 2022). "Association of County-Level Prescriptions for Hydroxychloroquine and Ivermectin With County-Level Political Voting Patterns in the 2020 US Presidential Election". JAMA Intern Med. 182 (4): 452–454. doi:10.1001/jamainternmed.2022.0200. PMC 8980920. PMID 35179552. S2CID 246943373.
Molento MB (December 2021). "Ivermectin against COVID-19: The unprecedented consequences in Latin America". One Health. 13: 100250. doi:10.1016/j.onehlt.2021.100250. PMC 8050401. PMID 33880395.

nih.gov

"COVID-19 Therapeutics Prioritized for Testing in Clinical Trials". National Institutes of Health. 21 July 2020. Archived from the original on 19 January 2022. Retrieved 27 June 2021.

covid19treatmentguidelines.nih.gov

"The COVID-19 Treatment Guidelines Panel's Statement on the Use of Ivermectin for the Treatment of COVID-19". National Institutes of Health. 14 January 2020. Archived from the original on 8 February 2021. Retrieved 23 December 2021.

nytimes.com

Woo E (28 September 2021). "How Covid Misinformation Created a Run on Animal Medicine". New York Times. Archived from the original on 7 January 2022. Retrieved 23 December 2021.
Qiu L (17 December 2020). "The election is over, but Ron Johnson keeps promoting false claims of fraud". The New York Times. ISSN 0362-4331. Archived from the original on 1 January 2021. Retrieved 18 December 2020.

pebmed.com.br

de Oliveira Quintanilha D (13 July 2020). "Anvisa se manifesta contra o uso da ivermectina na Covid-19" [Anvisa speaks out against the use of ivermectin in Covid-19]. PEBMED (in Portuguese). Archived from the original on 26 October 2021. Retrieved 23 December 2021.
"Posicionamento da Sociedade Brasileira de Pneumologia e Tisiologia Sobre o Colapso em Manaus e Tratamento Preventivo e Precoce da Covid-19" [Brazilian Thoracic Society Position Statement on the Collapse in Manaus and the Preventive and Early Treatment of Covid-19] (in Portuguese). Sociedade Brasileira de Pneumologia e Tisiologia. 17 January 2021. Archived from the original on 26 October 2021. Retrieved 18 January 2021.

politico.eu

"The rise and fall of a coronavirus 'miracle cure'". Politico. 30 March 2021. Archived from the original on 3 December 2021. Retrieved 31 May 2021.

retractionwatch.com

"Ivermectin papers slapped with expressions of concern". Retraction Watch. 11 February 2022. Archived from the original on 16 February 2022. Retrieved 16 February 2022.

reuters.com

Mishra M (13 May 2021). "Indian states turn to anti-parasitic drug to fight COVID-19 against WHO advice". Reuters. Archived from the original on 5 January 2022. Retrieved 30 May 2021.
"Ivermectin still not FDA-approved to treat COVID" (Fact check). Reuters. 30 August 2023.

sahpra.org.za

"FDA's stance on ivermectin aligned to SAHPRA's position". SAHPRA. 3 September 2021. Archived from the original on 23 December 2021. Retrieved 23 December 2021.
"SAHPRA statement on the termination of the "Ivermectin Controlled Compassionate Use Access Programme" -". SAHPRA. 30 May 2022. Archived from the original on 25 February 2023. Retrieved 25 February 2023.

science.org

Piller C, Servick K (4 June 2020). "Two elite medical journals retract coronavirus papers over data integrity questions". Science. Archived from the original on 14 October 2021. Retrieved 5 June 2020.
Servick K, Enserink M (2 June 2020). "A mysterious company's coronavirus papers in top medical journals may be unraveling". Science. AAAS. Archived from the original on 14 October 2021. Retrieved 3 June 2020.
Lowe D (11 May 2020). "What's Up With Ivermectin?". science.com. Archived from the original on 18 March 2023. Retrieved 4 June 2020.

sciencebasedmedicine.org

Gorski DH (15 April 2021). "Ivermectin is the new hydroxychloroquine". Science-Based Medicine. Archived from the original on 10 January 2022. Retrieved 23 December 2021.
Gorski DH (28 December 2020). "2020 and the pandemic: A year of (some) physicians behaving badly". Science-Based Medicine. Archived from the original on 23 December 2021. Retrieved 23 December 2021.
Gorski D (15 November 2021). "Pfizer's new COVID-19 protease inhibitor drug is not just 'repackaged ivermectin'". Science-Based Medicine. Archived from the original on 20 December 2021. Retrieved 23 December 2021.

semanticscholar.org

api.semanticscholar.org

Tafoya QJ (2021). "Appendix – COVID-19-Directed Medications". In Ramadan AR, Gamaleldin O (eds.). Neurological Care and the COVID-19 Pandemic (1st ed.). Elsevier. pp. 173–174. doi:10.1016/B978-0-323-82691-4.00016-9. ISBN 978-0-323-82691-4. S2CID 239763031. The WHO, the European Medicines Agency, and the IDSA all recommend against the use of ivermectin for treatment of COVID-19, with the NIH stating that there is insufficient data to recommend for or against its use outside the context of a clinical trial. (subscription required)
Lawrence JM, Meyerowitz-Katz G, Heathers JA, Brown NJ, Sheldrick KA (November 2021). "The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable". Nature Medicine. 27 (11): 1853–1854. doi:10.1038/s41591-021-01535-y. PMID 34552263. S2CID 237607620.
Yang SN, Atkinson SC, Wang C, Lee A, Bogoyevitch MA, et al. (May 2020). "The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer". Antiviral Research. 177: 104760. doi:10.1016/j.antiviral.2020.104760. PMID 32135219. S2CID 212565030.
Garegnani LI, Madrid E, Meza N (April 2021). "Misleading clinical evidence and systematic reviews on ivermectin for COVID-19". BMJ Evidence-Based Medicine. 27 (3): 156–158. doi:10.1136/bmjebm-2021-111678. PMID 33888547. S2CID 233354977.
Reardon S (August 2021). "Flawed ivermectin preprint highlights challenges of COVID drug studies". Nature. 596 (7871): 173–174. Bibcode:2021Natur.596..173R. doi:10.1038/d41586-021-02081-w. PMID 34341573. S2CID 236883132.
Manu P (7 February 2022). "Expression of Concern for Kory P, Meduri GU, Varon J, Iglesias J, Marik PE. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021;28(3) e299–e318". American Journal of Therapeutics. 29 (2): e231. doi:10.1097/MJT.0000000000001481. PMC 10501341. PMID 35142703. S2CID 246701186.
Wadvalla BA (April 2021). "Covid-19: Ivermectin's politicisation is a warning sign for doctors turning to orphan treatments". BMJ. 373: n747. doi:10.1136/bmj.n747. PMID 33795225. S2CID 232484313.
Mega ER (October 2020). "Latin America's embrace of an unproven COVID treatment is hindering drug trials". Nature. 586 (7830): 481–482. Bibcode:2020Natur.586..481M. doi:10.1038/d41586-020-02958-2. PMID 33077974. S2CID 224812404.
Barnett ML, Gaye M, Jena AB, Mehrotra A (February 2022). "Association of County-Level Prescriptions for Hydroxychloroquine and Ivermectin With County-Level Political Voting Patterns in the 2020 US Presidential Election". JAMA Intern Med. 182 (4): 452–454. doi:10.1001/jamainternmed.2022.0200. PMC 8980920. PMID 35179552. S2CID 246943373.
Nogrady B (13 October 2021). "'I hope you die': how the COVID pandemic unleashed attacks on scientists". Nature (News feature). 598 (7880): 250–253. Bibcode:2021Natur.598..250N. doi:10.1038/d41586-021-02741-x. PMID 34645996. S2CID 238858471. Archived from the original on 18 January 2022. Retrieved 3 January 2022.

smh.com.au

Alexander H (22 October 2021). "How a false science 'cure' became Australia's contribution to the pandemic". Sydney Morning Herald. Archived from the original on 22 December 2021. Retrieved 30 December 2021.

the-scientist.com

"Surgisphere Sows Confusion About Another Unproven COVID-19 Drug". The Scientist Magazine®. 16 June 2020. Archived from the original on 7 September 2020. Retrieved 9 July 2020.
"Lancet, NEJM Retract Surgisphere Studies on COVID-19 Patients". The Scientist Magazine®. Archived from the original on 11 January 2022. Retrieved 23 July 2021.
Offord C (2 March 2021). "Frontiers Removes Controversial Ivermectin Paper Pre-Publication". The Scientist. Archived from the original on 10 January 2022. Retrieved 23 December 2021.

theguardian.com

Melissa Davey (15 July 2021). "Huge study supporting ivermectin as Covid treatment withdrawn over ethical concerns". The Guardian. Archived from the original on 16 January 2022. Retrieved 12 May 2023.
Salam E (10 October 2023). "US prisoners who did not consent to ivermectin Covid treatment win payout". The Guardian.
Milman O (20 September 2021). "US horse owners face ivermectin shortage as humans chase unproven Covid 'cure'". The Guardian. Archived from the original on 11 January 2022. Retrieved 27 December 2021.
Pengelly M (23 August 2021). "'You are not a horse': FDA tells Americans stop taking dewormer for Covid". The Guardian. Archived from the original on 27 December 2021. Retrieved 27 December 2021.
"Doctor who advocated Covid-19 therapy including ivermectin applied for patent on same unproven treatment". The Guardian. 18 October 2021. Archived from the original on 21 November 2021. Retrieved 18 October 2021.
Butler J (22 February 2022). "Nine Network apologises for 'error' suggesting Queen may have used ivermectin to treat Covid". The Guardian. Archived from the original on 22 February 2022. Retrieved 22 February 2022.
Hill A (13 October 2021). "How my ivermectin research led to Twitter death threats". The Guardian. Archived from the original on 9 December 2021. Retrieved 30 December 2021.

theintercept.com

Lee M (28 September 2021). "Network of Right-Wing Health Care Providers Is Making Millions Off Hydroxychloroquine and Ivermectin, Hacked Data Reveals". The Intercept. Archived from the original on 16 January 2022. Retrieved 7 October 2021.

usatoday.com

"Fact check: No link between India's falling COVID-19 cases and hydroxychloroquine". USA Today. 21 May 2021. Archived from the original on 9 January 2022. Retrieved 25 May 2021.

vice.com

Merlan A (24 June 2021). "Why Is the Intellectual Dark Web Suddenly Hyping an Unproven COVID Treatment?". Vice. Archived from the original on 4 December 2021. Retrieved 23 December 2021.
Merlan A (1 July 2021). "The Ivermectin Advocates' War Has Just Begun". Vice. Archived from the original on 15 January 2022. Retrieved 1 July 2021.
Merlan A (24 June 2021). "Why Is the Intellectual Dark Web Suddenly Hyping an Unproven COVID Treatment?". Vice. Archived from the original on 4 December 2021. Retrieved 23 December 2021.

vox.com

Piper K (17 December 2021). "How bad research clouded our understanding of Covid-19". Vox. Archived from the original on 14 January 2022. Retrieved 28 December 2021.

washingtonpost.com

Kessler G (8 September 2021). "False meme: Nobel laureate did not say ivermectin 'cures' covid-19". Washington Post (Fact check). Archived from the original on 26 October 2021. Retrieved 15 January 2022.

watson.ch

Marjanović, Petar (4 February 2022). "Ivermectin-Studie geht viral – sie ist aber irreführend". watson.ch (Fact check) (in German). Archived from the original on 4 February 2022. Retrieved 4 February 2022.

web.archive.org

Woo E (28 September 2021). "How Covid Misinformation Created a Run on Animal Medicine". New York Times. Archived from the original on 7 January 2022. Retrieved 23 December 2021.
"Ivermectin: How false science created a Covid 'miracle' drug". BBC News. 6 October 2021. Archived from the original on 8 January 2022. Retrieved 26 December 2021.
Melissa Davey (15 July 2021). "Huge study supporting ivermectin as Covid treatment withdrawn over ethical concerns". The Guardian. Archived from the original on 16 January 2022. Retrieved 12 May 2023.
Schraer R (23 June 2021). "Covid: Ivermectin to be studied as possible treatment in UK". BBC News. Archived from the original on 15 December 2021. Retrieved 23 June 2021.
"COVID-19 Therapeutics Prioritized for Testing in Clinical Trials". National Institutes of Health. 21 July 2020. Archived from the original on 19 January 2022. Retrieved 27 June 2021.
Piller C, Servick K (4 June 2020). "Two elite medical journals retract coronavirus papers over data integrity questions". Science. Archived from the original on 14 October 2021. Retrieved 5 June 2020.
"Surgisphere Sows Confusion About Another Unproven COVID-19 Drug". The Scientist Magazine®. 16 June 2020. Archived from the original on 7 September 2020. Retrieved 9 July 2020.
Servick K, Enserink M (2 June 2020). "A mysterious company's coronavirus papers in top medical journals may be unraveling". Science. AAAS. Archived from the original on 14 October 2021. Retrieved 3 June 2020.
Lowe D (11 May 2020). "What's Up With Ivermectin?". science.com. Archived from the original on 18 March 2023. Retrieved 4 June 2020.
Cohen L (17 January 2022). "Arkansas inmates who were given ivermectin to treat COVID in jail file federal lawsuit: "They used us as an experiment" - CBS News". www.cbsnews.com. Archived from the original on 30 May 2023. Retrieved 6 August 2023.
"Ivermectin papers slapped with expressions of concern". Retraction Watch. 11 February 2022. Archived from the original on 16 February 2022. Retrieved 16 February 2022.
Cuenca A (4 February 2022). "Falso y engañoso estudio del GobCDMX sobre Ivermectina para tratar Covid". Capital CDMX (in Spanish). Archived from the original on 6 February 2022. Retrieved 6 February 2022.
Gorski DH (15 April 2021). "Ivermectin is the new hydroxychloroquine". Science-Based Medicine. Archived from the original on 10 January 2022. Retrieved 23 December 2021.
"Merck Statement on Ivermectin use During the COVID-19 Pandemic". Merck. 4 February 2021. Archived from the original on 16 January 2022. Retrieved 23 December 2021.
"EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials" (Press release). European Medicines Agency. 22 March 2021. Archived from the original on 17 January 2022. Retrieved 23 December 2021.
"The COVID-19 Treatment Guidelines Panel's Statement on the Use of Ivermectin for the Treatment of COVID-19". National Institutes of Health. 14 January 2020. Archived from the original on 8 February 2021. Retrieved 23 December 2021.
de Oliveira Quintanilha D (13 July 2020). "Anvisa se manifesta contra o uso da ivermectina na Covid-19" [Anvisa speaks out against the use of ivermectin in Covid-19]. PEBMED (in Portuguese). Archived from the original on 26 October 2021. Retrieved 23 December 2021.
"Atualizações e Recomendações sobre a Covid-19" [Updates and recommendations on Covid-19] (PDF) (in Portuguese). Sociedade Brasileira de Infectologia. 9 December 2020. Archived (PDF) from the original on 20 October 2021. Retrieved 23 December 2021.
"Posicionamento da Sociedade Brasileira de Pneumologia e Tisiologia Sobre o Colapso em Manaus e Tratamento Preventivo e Precoce da Covid-19" [Brazilian Thoracic Society Position Statement on the Collapse in Manaus and the Preventive and Early Treatment of Covid-19] (in Portuguese). Sociedade Brasileira de Pneumologia e Tisiologia. 17 January 2021. Archived from the original on 26 October 2021. Retrieved 18 January 2021.
"The rise and fall of a coronavirus 'miracle cure'". Politico. 30 March 2021. Archived from the original on 3 December 2021. Retrieved 31 May 2021.
"FDA's stance on ivermectin aligned to SAHPRA's position". SAHPRA. 3 September 2021. Archived from the original on 23 December 2021. Retrieved 23 December 2021.
"SAHPRA statement on the termination of the "Ivermectin Controlled Compassionate Use Access Programme" -". SAHPRA. 30 May 2022. Archived from the original on 25 February 2023. Retrieved 25 February 2023.
Ferrer A (22 January 2021). "Médicos en CDMX suministran ivermectina y azitromicina para tratar pacientes con COVID-19". El Financiero (in Spanish). Archived from the original on 23 October 2021. Retrieved 18 July 2021.
Andina (13 October 2020). "Covid-19: Minsa aprueba resolución que deja sin efecto el uso de tres medicamentos" (in Spanish). Agencia Peruana de Noticias. Archived from the original on 26 October 2021. Retrieved 23 December 2021.
Calderon D (22 January 2021). "Ivermectina vuelve a ser incluida en tratamiento covid-19". Diario Extra (in Spanish). Extra. Archived from the original on 26 October 2021. Retrieved 23 December 2021.
Mishra M (13 May 2021). "Indian states turn to anti-parasitic drug to fight COVID-19 against WHO advice". Reuters. Archived from the original on 5 January 2022. Retrieved 30 May 2021.
"Fact check: No link between India's falling COVID-19 cases and hydroxychloroquine". USA Today. 21 May 2021. Archived from the original on 9 January 2022. Retrieved 25 May 2021.
Mordani S (7 June 2021). "DGHS drops Ivermectin, Doxycycline from Covid-19 treatment; ICMR rules unchanged". India Today. Archived from the original on 24 December 2021. Retrieved 18 July 2021.
"FDA approves drug company's request to manufacture ivermectin". The Manila Times. 7 May 2021. Archived from the original on 23 December 2021. Retrieved 18 July 2021.
Casa Editorial El País Cali. "Empezarán a usar Ivermectina en tratamiento de pacientes covid en Cali, dice Ospina". elpais.com.co (in Spanish). El País. Archived from the original on 22 December 2021. Retrieved 12 July 2021.
Prefeitura de Itajaí (6 July 311). "Itajaí vai implantar tratamento profilático à COVID-19 | Município de Itajaí". Prefeitura de Itajaí. Archived from the original on 22 December 2021. Retrieved 22 December 2021.
"WHO advises that ivermectin only be used to treat COVID-19 within clinical trials". World Health Organization. 31 March 2021. Archived from the original on 5 August 2021. Retrieved 23 December 2021.
"Lancet, NEJM Retract Surgisphere Studies on COVID-19 Patients". The Scientist Magazine®. Archived from the original on 11 January 2022. Retrieved 23 July 2021.
U.S. FDA [@US_FDA] (21 August 2021). "You are not a horse. You are not a cow. Seriously, y'all. Stop it" (Tweet). Archived from the original on 21 August 2021 – via Twitter.
Milman O (20 September 2021). "US horse owners face ivermectin shortage as humans chase unproven Covid 'cure'". The Guardian. Archived from the original on 11 January 2022. Retrieved 27 December 2021.
Pengelly M (23 August 2021). "'You are not a horse': FDA tells Americans stop taking dewormer for Covid". The Guardian. Archived from the original on 27 December 2021. Retrieved 27 December 2021.
Einhorn B, Kay C (13 October 2021). "Ivermectin Doesn't Help Covid, But Generic Drug Makers Are Cashing In". Bloomberg Businessweek. Archived from the original on 26 November 2021. Retrieved 30 December 2021.
Alexander H (22 October 2021). "How a false science 'cure' became Australia's contribution to the pandemic". Sydney Morning Herald. Archived from the original on 22 December 2021. Retrieved 30 December 2021.
"Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox". BioSpace. 15 October 2021. Archived from the original on 19 October 2021. Retrieved 18 October 2021.
"Doctor who advocated Covid-19 therapy including ivermectin applied for patent on same unproven treatment". The Guardian. 18 October 2021. Archived from the original on 21 November 2021. Retrieved 18 October 2021.
Lee M (28 September 2021). "Network of Right-Wing Health Care Providers Is Making Millions Off Hydroxychloroquine and Ivermectin, Hacked Data Reveals". The Intercept. Archived from the original on 16 January 2022. Retrieved 7 October 2021.
Dupuy B (11 December 2020). "No evidence ivermectin is a miracle drug against COVID-19" (Fact check). AP News. Archived from the original on 28 December 2021. Retrieved 23 December 2021.
Sharma R (24 February 2021). "What is Ivermectin? Why social media creates Covid 'miracle drugs' – and why you shouldn't trust the crowd". inews.co.uk. Archived from the original on 23 December 2021. Retrieved 23 December 2021.
Merlan A (24 June 2021). "Why Is the Intellectual Dark Web Suddenly Hyping an Unproven COVID Treatment?". Vice. Archived from the original on 4 December 2021. Retrieved 23 December 2021.
Merlan A (1 July 2021). "The Ivermectin Advocates' War Has Just Begun". Vice. Archived from the original on 15 January 2022. Retrieved 1 July 2021.
Satherley D (26 November 2021). "Did mutations or ivermectin help stamp out Delta in Japan?". Newshub (Fact check). Archived from the original on 14 January 2022. Retrieved 23 December 2021.
Marjanović, Petar (4 February 2022). "Ivermectin-Studie geht viral – sie ist aber irreführend". watson.ch (Fact check) (in German). Archived from the original on 4 February 2022. Retrieved 4 February 2022.
Chaccour C. "Ivermectin and COVID-19: How a Flawed Database Shaped the Pandemic Response of Several Latin-American Countries - Blog". ISGlobal. Archived from the original on 6 November 2021. Retrieved 23 June 2021.
Merlan A (24 June 2021). "Why Is the Intellectual Dark Web Suddenly Hyping an Unproven COVID Treatment?". Vice. Archived from the original on 4 December 2021. Retrieved 23 December 2021.
Davis JJ. "Will Ivermectin Cure COVID-19?". opmed.doximity.com. Archived from the original on 25 May 2021. Retrieved 23 June 2021.
"Drew University Nobel Prize Winner Refutes Ivermectin Meme". Drew University. September 2021. Archived from the original on 15 January 2022. Retrieved 15 January 2022.
Kessler G (8 September 2021). "False meme: Nobel laureate did not say ivermectin 'cures' covid-19". Washington Post (Fact check). Archived from the original on 26 October 2021. Retrieved 15 January 2022.
Butler J (22 February 2022). "Nine Network apologises for 'error' suggesting Queen may have used ivermectin to treat Covid". The Guardian. Archived from the original on 22 February 2022. Retrieved 22 February 2022.
Nogrady B (13 October 2021). "'I hope you die': how the COVID pandemic unleashed attacks on scientists". Nature (News feature). 598 (7880): 250–253. Bibcode:2021Natur.598..250N. doi:10.1038/d41586-021-02741-x. PMID 34645996. S2CID 238858471. Archived from the original on 18 January 2022. Retrieved 3 January 2022.
Hill A (13 October 2021). "How my ivermectin research led to Twitter death threats". The Guardian. Archived from the original on 9 December 2021. Retrieved 30 December 2021.
Qiu L (17 December 2020). "The election is over, but Ron Johnson keeps promoting false claims of fraud". The New York Times. ISSN 0362-4331. Archived from the original on 1 January 2021. Retrieved 18 December 2020.
Offord C (2 March 2021). "Frontiers Removes Controversial Ivermectin Paper Pre-Publication". The Scientist. Archived from the original on 10 January 2022. Retrieved 23 December 2021.
Gorski DH (28 December 2020). "2020 and the pandemic: A year of (some) physicians behaving badly". Science-Based Medicine. Archived from the original on 23 December 2021. Retrieved 23 December 2021.
Gorski D (15 November 2021). "Pfizer's new COVID-19 protease inhibitor drug is not just 'repackaged ivermectin'". Science-Based Medicine. Archived from the original on 20 December 2021. Retrieved 23 December 2021.
"Pfizer's new pill to prevent COVID-19 is not the same as ivermectin". AP NEWS. 1 October 2021. Archived from the original on 23 January 2022. Retrieved 23 January 2022.
Piper K (17 December 2021). "How bad research clouded our understanding of Covid-19". Vox. Archived from the original on 14 January 2022. Retrieved 28 December 2021.
Meyerowitz-Katz G (11 December 2021). "'Science is flawed': COVID-19, ivermectin, and beyond". Medical News Today. Archived from the original on 12 January 2022. Retrieved 28 December 2021.

who.int

"WHO advises that ivermectin only be used to treat COVID-19 within clinical trials". Newsroom. World Health Organization. Geneva, Switzerland. 31 March 2021. Retrieved 12 May 2023.
Ashok Moloo (17 December 2020). "A parasitic infection that can turn fatal with administration of corticosteroids". News. World Health Organization. Geneva, Switzerland. Retrieved 12 May 2023.
"WHO advises that ivermectin only be used to treat COVID-19 within clinical trials". World Health Organization. 31 March 2021. Archived from the original on 5 August 2021. Retrieved 23 December 2021.

worldcat.org

search.worldcat.org

Wagstaff K, Sivakumaran H, Heaton S, Harrich D, Jans D (1 May 2012). "Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus". Biochemical Journal. 443 (Pt 3): 851–856. doi:10.1042/BJ20120150. ISSN 0264-6021. PMC 3327999. PMID 22417684.
Qiu L (17 December 2020). "The election is over, but Ron Johnson keeps promoting false claims of fraud". The New York Times. ISSN 0362-4331. Archived from the original on 1 January 2021. Retrieved 18 December 2020.

x.com

U.S. FDA [@US_FDA] (21 August 2021). "You are not a horse. You are not a cow. Seriously, y'all. Stop it" (Tweet). Archived from the original on 21 August 2021 – via Twitter.